FDAFDA · Food and drugs·Recall number D-0576-2022
Azacitidine, 100mg/vial, One Single-dose Vial, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, India, NDC 43598-465-62
Published March 2, 2022 · Recall initiated: January 19, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed stability specifications
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- AZACITIDINE
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Distributor
- USA Nationwide
- Lot
- Lot#: H200107, Exp 8/1/2023; H200154, Exp 9/1/2023; H210020, Exp 11/1/2023; H210055, Exp 12/1/2023; H210129, Exp 1/1/2024, H210288, Exp 4/1/2024.
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.